Topotecan Delivery to the Optic Nerve after Ophthalmic Artery Chemosurgery

• Paula Taich,

  Affiliations Clinical Pharmacokinetics Unit, Hospital de Pediatría JP Garrahan, Buenos Aires, Argentina, National Scientific and Technical Research Council, CONICET, Buenos Aires, Argentina

  ⨯
• Flavio Requejo,

  Affiliation Service of Interventional Radiology, Hospital de Pediatría JP Garrahan, Buenos Aires, Argentina

  ⨯
• Marcelo Asprea,

  Affiliation Animal facility, Laboratory, Hospital de Pediatria J.P. Garrahan, Buenos Aires, Argentina

  ⨯
• Mariana Sgroi,

  Affiliation Service of Ophthalmology, Hospital de Pediatría JP Garrahan, Buenos Aires, Argentina

  ⨯
• Pierre Gobin,

  Affiliation Ophthalmic Oncology Service, Memorial Sloan-Kettering Center Cancer Center, New York, United States of America

  ⨯
• David H. Abramson,

  Affiliation Ophthalmic Oncology Service, Memorial Sloan-Kettering Center Cancer Center, New York, United States of America

  ⨯
• Guillermo Chantada,

  Affiliation Research Institute at Hospital de Pediatría JP Garrahan, Buenos Aires, Argentina

  ⨯
• Paula Schaiquevich

  * E-mail: paulas@conicet.gov.ar

  Affiliations Clinical Pharmacokinetics Unit, Hospital de Pediatría JP Garrahan, Buenos Aires, Argentina, National Scientific and Technical Research Council, CONICET, Buenos Aires, Argentina

  ⨯